{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:56:29Z","timestamp":1790772989656,"version":"4.1.0"},"publisher-location":"New York, NY","reference-count":100,"publisher":"Springer US","isbn-type":[{"value":"9781071654750","type":"print"},{"value":"9781071654767","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5476-7_12","type":"book-chapter","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:34:46Z","timestamp":1790764486000},"page":"183-204","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["LncRNA Knockdown Using Gapmer Antisense Oligonucleotides"],"prefix":"10.1007","author":[{"given":"Kim A.","family":"Lennox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Behlke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"12_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature11233","volume":"489","author":"S Djebali","year":"2012","unstructured":"Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F et al (2012) Landscape of transcription in human cells. Nature 489:101\u2013108","journal-title":"Nature"},{"key":"12_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41422-024-00975-8","volume":"34","author":"L Poliseno","year":"2024","unstructured":"Poliseno L, Lanza M, Pandolfi PP (2024) Coding, or non-coding, that is the question. Cell Res 34:609\u2013629","journal-title":"Cell Res"},{"key":"12_CR3","doi-asserted-by":"publisher","first-page":"925","DOI":"10.4161\/rna.24604","volume":"10","author":"L Ma","year":"2013","unstructured":"Ma L, Bajic VB, Zhang Z (2013) On the classification of long non-coding RNAs. RNA Biol 10:925\u2013933","journal-title":"RNA Biol"},{"key":"12_CR4","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JS Mattick","year":"2023","unstructured":"Mattick JS, Amaral PP, Carninci P, Carpenter S, Chang HY, Chen LL, Chen R, Dean C, Dinger ME, Fitzgerald KA et al (2023) Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol 24:430\u2013447","journal-title":"Nat Rev Mol Cell Biol"},{"key":"12_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrg.2015.10","volume":"17","author":"JJ Quinn","year":"2016","unstructured":"Quinn JJ, Chang HY (2016) Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet 17:47\u201362","journal-title":"Nat Rev Genet"},{"key":"12_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cell.2013.06.020","volume":"154","author":"I Ulitsky","year":"2013","unstructured":"Ulitsky I, Bartel DP (2013) lincRNAs: genomics, evolution, and mechanisms. Cell 154:26\u201346","journal-title":"Cell"},{"key":"12_CR7","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nrm3679","volume":"14","author":"S Geisler","year":"2013","unstructured":"Geisler S, Coller J (2013) RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts. Nat Rev Mol Cell Biol 14:699\u2013712","journal-title":"Nat Rev Mol Cell Biol"},{"key":"12_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-biochem-051410-092902","volume":"81","author":"JL Rinn","year":"2012","unstructured":"Rinn JL, Chang HY (2012) Genome regulation by long noncoding RNAs. Annu Rev Biochem 81:145\u2013166","journal-title":"Annu Rev Biochem"},{"key":"12_CR9","doi-asserted-by":"publisher","first-page":"e944014","DOI":"10.4161\/21541272.2014.944014","volume":"5","author":"BK Dey","year":"2014","unstructured":"Dey BK, Mueller AC, Dutta A (2014) Long non-coding RNAs as emerging regulators of differentiation, development, and disease. Transcription 5:e944014","journal-title":"Transcription"},{"key":"12_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature21034","volume":"541","author":"A Matsumoto","year":"2017","unstructured":"Matsumoto A, Pasut A, Matsumoto M, Yamashita R, Fung J, Monteleone E, Saghatelian A, Nakayama KI, Clohessy JG, Pandolfi PP (2017) mTORC1 and muscle regeneration are regulated by the LINC00961-encoded SPAR polypeptide. Nature 541:228\u2013232","journal-title":"Nature"},{"key":"12_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20225573","volume":"20","author":"X Zhang","year":"2019","unstructured":"Zhang X, Wang W, Zhu W, Dong J, Cheng Y, Yin Z, Shen F (2019) Mechanisms and functions of long non-coding RNAs at multiple regulatory levels. Int J Mol Sci 20, 5573","journal-title":"Int J Mol Sci"},{"key":"12_CR12","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.tcb.2017.04.006","volume":"27","author":"CA Makarewich","year":"2017","unstructured":"Makarewich CA, Olson EN (2017) Mining for micropeptides. Trends Cell Biol 27:685\u2013696","journal-title":"Trends Cell Biol"},{"key":"12_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-1147-3","volume":"19","author":"P Wu","year":"2020","unstructured":"Wu P, Mo Y, Peng M, Tang T, Zhong Y, Deng X, Xiong F, Guo C, Wu X, Li Y et al (2020) Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA. Mol Cancer 19:22","journal-title":"Mol Cancer"},{"key":"12_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.tcb.2021.10.010","volume":"32","author":"BW Wright","year":"2022","unstructured":"Wright BW,Yi Z,Weissman JS, Chen J (2022) The dark proteome: translation from noncanonical open reading frames. Trends Cell Biol 32:243\u2013258","journal-title":"Trends Cell Biol"},{"key":"12_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M (2021) Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol 22:96\u2013118","journal-title":"Nat Rev Mol Cell Biol"},{"key":"12_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ncrna.2025.01.004","volume":"11","author":"B Chodurska","year":"2025","unstructured":"Chodurska B, Kunej T (2025) Long non-coding RNAs in humans: classification, genomic organization and function. Noncoding RNA Res 11:313\u2013327","journal-title":"Noncoding RNA Res"},{"key":"12_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-1-r6","volume":"15","author":"S van Heesch","year":"2014","unstructured":"van Heesch S, van Iterson M, Jacobi J, Boymans S, Essers PB, de Bruijn E, Hao W, MacInnes AW, Cuppen E, Simonis M (2014) Extensive localization of long noncoding RNAs to the cytosol and mono- and polyribosomal complexes. Genome Biol 15:R6","journal-title":"Genome Biol"},{"key":"12_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0586-4","volume":"16","author":"MN Cabili","year":"2015","unstructured":"Cabili MN, Dunagin MC, McClanahan PD, Biaesch A, Padovan-Merhar O, Regev A, Rinn JL, Raj A (2015) Localization and abundance analysis of human lncRNAs at single-cell and single-molecule resolution. Genome Biol 16:20","journal-title":"Genome Biol"},{"key":"12_CR19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12929-024-01038-1","volume":"31","author":"S Sharma","year":"2024","unstructured":"Sharma S, Houfani AA, Foster LJ (2024) Pivotal functions and impact of long con-coding RNAs on cellular processes and genome integrity. J Biomed Sci 31:52","journal-title":"J Biomed Sci"},{"key":"12_CR20","first-page":"127","volume":"4","author":"L Nie","year":"2012","unstructured":"Nie L, Wu HJ, Hsu JM, Chang SS, Labaff AM, Li CW, Wang Y, Hsu JL, Hung MC (2012) Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer. Am J Transl Res 4:127\u2013150","journal-title":"Am J Transl Res"},{"key":"12_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fgene.2012.00025","volume":"3","author":"CN Niland","year":"2012","unstructured":"Niland CN, Merry CR, Khalil AM (2012) Emerging roles for long non-coding RNAs in cancer and neurological disorders. Front Genet 3:25","journal-title":"Front Genet"},{"key":"12_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.flm.2018.07.004","volume":"2","author":"J Wang","year":"2018","unstructured":"Wang J, Wei F, Zhou H (2018) Advances of lncRNA in autoimmune diseases. Front Lab Med 2:79\u201382","journal-title":"Front Lab Med"},{"key":"12_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-018-0188-9","volume":"50","author":"R Yarani","year":"2018","unstructured":"Yarani R, Mirza AH, Kaur S, Pociot F (2018) The emerging role of lncRNAs in inflammatory bowel disease. Exp Mol Med 50:161","journal-title":"Exp Mol Med"},{"key":"12_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jaut.2017.03.014","volume":"81","author":"TM Aune","year":"2017","unstructured":"Aune TM, Crooke PS, Patrick AE, Tossberg JT, Olsen NJ, Spurlock CF (2017) Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants. J Autoimmun 81:99\u2013109","journal-title":"J Autoimmun"},{"key":"12_CR25","doi-asserted-by":"publisher","first-page":"18648","DOI":"10.18632\/oncotarget.24307","volume":"9","author":"G Hu","year":"2018","unstructured":"Hu G, Niu F, Humburg BA, Liao K, Bendi S, Callen S, Fox HS, Buch S (2018) Molecular mechanisms of long noncoding RNAs and their role in disease pathogenesis. Oncotarget 9:18648\u201318663","journal-title":"Oncotarget"},{"key":"12_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fnbeh.2018.00175","volume":"12","author":"CW Wei","year":"2018","unstructured":"Wei CW, Luo T, Zou SS, Wu AS (2018) The role of long noncoding RNAs in central nervous system and neurodegenerative diseases. Front Behav Neurosci 12:175","journal-title":"Front Behav Neurosci"},{"key":"12_CR27","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/cas.13642","volume":"109","author":"A Sanchez Calle","year":"2018","unstructured":"Sanchez Calle A, Kawamura Y, Yamamoto Y, Takeshita F, Ochiya T (2018) Emerging roles of long non-coding RNA in cancer. Cancer Sci 109:2093\u20132100","journal-title":"Cancer Sci"},{"key":"12_CR28","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3389\/fonc.2020.01057","volume":"10","author":"YB Pan","year":"2020","unstructured":"Pan YB, Zhu Y, Zhang QW, Zhang CH, Shao A, Zhang J (2020) Prognostic and predictive value of a long non-coding RNA signature in glioma: a lncRNA expression analysis. Front Oncol 10:1057","journal-title":"Front Oncol"},{"key":"12_CR29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.yjmcc.2019.01.019","volume":"128","author":"K Al-Hasani","year":"2019","unstructured":"Al-Hasani K, Mathiyalagan P, El-Osta A (2019) Epigenetics, cardiovascular disease, and cellular reprogramming. J Mol Cell Cardiol 128:129\u2013133","journal-title":"J Mol Cell Cardiol"},{"key":"12_CR30","doi-asserted-by":"publisher","first-page":"108249","DOI":"10.1016\/j.diabres.2020.108249","volume":"168","author":"Y Wang","year":"2020","unstructured":"Wang Y, Sun X (2020) The functions of LncRNA in the heart. Diabetes Res Clin Pract 168:108249","journal-title":"Diabetes Res Clin Pract"},{"key":"12_CR31","doi-asserted-by":"publisher","first-page":"100044","DOI":"10.1016\/j.jtauto.2020.100044","volume":"3","author":"Y Zou","year":"2020","unstructured":"Zou Y, Xu H (2020) Involvement of long noncoding RNAs in the pathogenesis of autoimmune diseases. J Transl Autoimmun 3:100044","journal-title":"J Transl Autoimmun"},{"key":"12_CR32","doi-asserted-by":"publisher","first-page":"e13156","DOI":"10.1111\/obr.13156","volume":"22","author":"SN Wijesinghe","year":"2021","unstructured":"Wijesinghe SN, Nicholson T, Tsintzas K, Jones SW (2021) Involvements of long noncoding RNAs in obesity-associated inflammatory diseases. Obes Rev 22:e13156","journal-title":"Obes Rev"},{"key":"12_CR33","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1042\/CS20190372","volume":"133","author":"J Guo","year":"2019","unstructured":"Guo J, Liu Z, Gong R (2019) Long noncoding RNA: an emerging player in diabetes and diabetic kidney disease. Clin Sci 133:1321\u20131339","journal-title":"Clin Sci"},{"key":"12_CR34","doi-asserted-by":"publisher","first-page":"602597","DOI":"10.3389\/fendo.2021.602597","volume":"12","author":"C Dieter","year":"2021","unstructured":"Dieter C, Lemos NE, Correa NRF, Assmann TS, Crispim D (2021) The impact of lncRNAs in diabetes mellitus: a systematic review and in silico analyses. Front Endocrinol 12:602597","journal-title":"Front Endocrinol"},{"issue":"12","key":"12_CR35","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.1007\/s11010-025-05368-y","volume":"480","author":"P Ramesh","year":"2025","unstructured":"Ramesh P, Muthyala P, Kali SK (2025) Deciphering the enigma: long noncoding RNAs in disease pathogenesis and therapeutic prospects. Mol Cell Biochem 480(12):5977\u20135993","journal-title":"Mol Cell Biochem"},{"key":"12_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17146-y","volume":"7","author":"ZL Chen","year":"2017","unstructured":"Chen ZL, Wei LL, Shi LY, Li M, Jiang TT, Chen J, Liu CM, Yang S, Tu HH, Hu YT et al  (2017) Screening and identification of lncRNAs as potential biomarkers for pulmonary tuberculosis. Sci Rep 7:16751","journal-title":"Sci Rep"},{"key":"12_CR37","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fcimb.2017.00205","volume":"7","author":"W Liu","year":"2017","unstructured":"Liu W, Ding C (2017) Roles of LncRNAs in viral infections. Front Cell Infect Microbiol 7:205","journal-title":"Front Cell Infect Microbiol"},{"key":"12_CR38","doi-asserted-by":"publisher","first-page":"7243968","DOI":"10.1155\/2017\/7243968","volume":"2017","author":"L Bolha","year":"2017","unstructured":"Bolha L, Ravnik-Glavac M, Glavac D (2017) Long noncoding RNAs as biomarkers in cancer. Dis Markers 2017:7243968","journal-title":"Dis Markers"},{"key":"12_CR39","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2217\/bmm-2016-0039","volume":"10","author":"X Jiang","year":"2016","unstructured":"Jiang X, Lei R, Ning Q (2016) Circulating long noncoding RNAs as novel biomarkers of human diseases. Biomark Med 10:757\u2013769","journal-title":"Biomark Med"},{"key":"12_CR40","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.atherosclerosis.2018.06.866","volume":"275","author":"L Li","year":"2018","unstructured":"Li L, Wang L, Li H, Han X, Chen S, Yang B, Hu Z, Zhu H, Cai C, Chen J et al (2018) Characterization of LncRNA expression profile and identification of novel LncRNA biomarkers to diagnose coronary artery disease. Atherosclerosis 275:359\u2013367","journal-title":"Atherosclerosis"},{"key":"12_CR41","doi-asserted-by":"publisher","first-page":"D190","DOI":"10.1093\/nar\/gkab998","volume":"50","author":"L Liu","year":"2022","unstructured":"Liu L, Li Z, Liu C, Zou D, Li Q, Feng C, Jing W, Luo S, Zhang Z, Ma L (2022) LncRNAWiki 2.0: a knowledgebase of human long non-coding RNAs with enhanced curation model and database system. Nucleic Acids Res 50:D190\u2013D195","journal-title":"Nucleic Acids Res"},{"key":"12_CR42","doi-asserted-by":"publisher","first-page":"D186","DOI":"10.1093\/nar\/gkac999","volume":"51","author":"Z Li","year":"2023","unstructured":"Li Z, Liu L, Feng C, Qin Y, Xiao J, Zhang Z, Ma L (2023) LncBook 2.0: integrating human long non-coding RNAs with multi-omics annotations. Nucleic Acids Res 51:D186\u2013D191","journal-title":"Nucleic Acids Res"},{"key":"12_CR43","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/nar\/gkv1206","volume":"44","author":"KA Lennox","year":"2016","unstructured":"Lennox KA, Behlke MA (2016) Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides. Nucleic Acids Res 44:863\u2013877","journal-title":"Nucleic Acids Res"},{"key":"12_CR44","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.1128\/MCB.00619-10","volume":"30","author":"Y Suzuki","year":"2010","unstructured":"Suzuki Y, Holmes JB, Cerritelli SM, Sakhuja K, Minczuk M, Holt IJ, Crouch RJ (2010) An upstream open reading frame and the context of the two AUG codons affect the abundance of mitochondrial and nuclear RNase H1. Mol Cell Biol 30:5123\u20135134","journal-title":"Mol Cell Biol"},{"key":"12_CR45","unstructured":"Lima WF, Wu H, Crooke ST (2007) Antisense Drug Technology: Principles, Strategies, and Applications. CRC Press, Boca Raton, vol 2. 2nd edn pp. 47\u201374"},{"key":"12_CR46","doi-asserted-by":"publisher","first-page":"e71006","DOI":"10.1371\/journal.pone.0071006","volume":"8","author":"H Wu","year":"2013","unstructured":"Wu H, Sun H, Liang X, Lima WF, Crooke ST (2013) Human RNase H1 is associated with protein P32 and is involved in mitochondrial pre-rRNA processing. PLoS One 8:e71006","journal-title":"PLoS One"},{"key":"12_CR47","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/j.ymthe.2017.06.002","volume":"25","author":"XH Liang","year":"2017","unstructured":"Liang XH, Sun H, Nichols JG, Crooke ST (2017) RNase H1-dependent antisense oligonucleotides are robustly active in directing RNA cleavage in both the cytoplasm and the nucleus. Mol Ther 25:2075\u20132092","journal-title":"Mol Ther"},{"key":"12_CR48","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nsmb886","volume":"12","author":"GB Robb","year":"2005","unstructured":"Robb GB, Brown KM, Khurana J, Rana TM (2005) Specific and potent RNAi in the nucleus of human cells. Nat Struct Mol Biol 12:133\u2013137","journal-title":"Nat Struct Mol Biol"},{"key":"12_CR49","doi-asserted-by":"publisher","first-page":"100416","DOI":"10.1016\/j.jbc.2021.100416","volume":"296","author":"ST Crooke","year":"2021","unstructured":"Crooke ST, Liang XH, Baker BF, Crooke RM (2021) Antisense technology: a review. J Biol Chem 296:100416","journal-title":"J Biol Chem"},{"key":"12_CR50","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1089\/ard.1991.1.141","volume":"1","author":"PS Eder","year":"1991","unstructured":"Eder PS, DeVine RJ, Dagle JM, Walder JA (1991) Substrate specificity and kinetics of degradation of antisense oligonucleotides by a 3\u2019 exonuclease in plasma. Antisense Res Dev 1:141\u2013151","journal-title":"Antisense Res Dev"},{"key":"12_CR51","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1038\/mtna.2013.46","volume":"2","author":"KA Lennox","year":"2013","unstructured":"Lennox KA, Owczarzy R, Thomas DM, Walder JA, Behlke MA (2013) Improved performance of anti-miRNA oligonucleotides using a novel non-nucleotide modifier. Mol Ther Nucleic Acids 2:e117","journal-title":"Mol Ther Nucleic Acids"},{"key":"12_CR52","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-0716-4742-4_3","volume":"2965","author":"KA Lennox","year":"2025","unstructured":"Lennox KA, Young RC, Behlke MA (2025) Chemical modifications in nucleic acid therapeutics. Methods Mol Biol 2965:57\u2013126","journal-title":"Methods Mol Biol"},{"key":"12_CR53","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1093\/nar\/gkx1239","volume":"46","author":"X Shen","year":"2018","unstructured":"Shen X, Corey DR (2018) Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs. Nucleic Acids Res 46:1584\u20131600","journal-title":"Nucleic Acids Res"},{"key":"12_CR54","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nbt.3765","volume":"35","author":"A Khvorova","year":"2017","unstructured":"Khvorova A, Watts JK (2017) The chemical evolution of oligonucleotide therapies of clinical utility. Nat Biotechnol 35:238\u2013248","journal-title":"Nat Biotechnol"},{"key":"12_CR55","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1093\/nar\/16.8.3209","volume":"16","author":"CA Stein","year":"1988","unstructured":"Stein CA, Subasinghe C, Shinozuka K, Cohen JS (1988) Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res 16:3209\u20133221","journal-title":"Nucleic Acids Res"},{"key":"12_CR56","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S1357-4310(99)01638-X","volume":"6","author":"S Agrawal","year":"2000","unstructured":"Agrawal S, Kandimalla ER (2000) Antisense therapeutics: is it as simple as complementary base recognition?. Mol Med Today 6:72\u201381","journal-title":"Mol Med Today"},{"key":"12_CR57","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1089\/nat.2014.0506","volume":"24","author":"F Eckstein","year":"2014","unstructured":"Eckstein F (2014) Phosphorothioates, essential components of therapeutic oligonucleotides. Nucleic Acid Ther 24:374\u2013387","journal-title":"Nucleic Acid Ther"},{"key":"12_CR58","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nbt.3802","volume":"35","author":"SF Dowdy","year":"2017","unstructured":"Dowdy SF (2017) Overcoming cellular barriers for RNA therapeutics. Nat Biotechnol 35:222\u2013229","journal-title":"Nat Biotechnol"},{"key":"12_CR59","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.addr.2015.01.008","volume":"87","author":"RS Geary","year":"2015","unstructured":"Geary RS, Norris D, Yu R, Bennett CF (2015) Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides. Adv Drug Deliv Rev 87:46\u201351","journal-title":"Adv Drug Deliv Rev"},{"key":"12_CR60","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.1093\/nar\/gkr089","volume":"39","author":"E Koller","year":"2011","unstructured":"Koller E, Vincent TM, Chappell A, De S, Manoharan M, Bennett CF (2011) Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes. Nucleic Acids Res 39:4795\u20134807","journal-title":"Nucleic Acids Res"},{"key":"12_CR61","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.1093\/nar\/gkaa299","volume":"48","author":"ST Crooke","year":"2020","unstructured":"Crooke ST, Vickers TA, Liang XH (2020) Phosphorothioate modified oligonucleotide-protein interactions. Nucleic Acids Res 48:5235\u20135253","journal-title":"Nucleic Acids Res"},{"key":"12_CR62","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1093\/nar\/gkw144","volume":"44","author":"XH Liang","year":"2016","unstructured":"Liang XH, Shen W, Sun H, Kinberger GA, Prakash TP, Nichols JG, Crooke ST (2016) Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2\u2019-modifications and enhances antisense activity. Nucleic Acids Res 44:3892\u20133907","journal-title":"Nucleic Acids Res"},{"key":"12_CR63","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nbt.3779","volume":"35","author":"ST Crooke","year":"2017","unstructured":"Crooke ST, Wang S, Vickers TA, Shen W, Liang XH (2017) Cellular uptake and trafficking of antisense oligonucleotides. Nat Biotechnol 35:230\u2013237","journal-title":"Nat Biotechnol"},{"key":"12_CR64","doi-asserted-by":"publisher","first-page":"10649","DOI":"10.1093\/nar\/gkx709","volume":"45","author":"JK Bailey","year":"2017","unstructured":"Bailey JK, Shen W, Liang XH, Crooke ST (2017) Nucleic acid binding proteins affect the subcellular distribution of phosphorothioate antisense oligonucleotides. Nucleic Acids Res 45:10649\u201310671","journal-title":"Nucleic Acids Res"},{"key":"12_CR65","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1093\/nar\/gkv143","volume":"43","author":"XH Liang","year":"2015","unstructured":"Liang XH, Sun H, Shen W, Crooke ST (2015) Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages. Nucleic Acids Res 43:2927\u20132945","journal-title":"Nucleic Acids Res"},{"key":"12_CR66","doi-asserted-by":"publisher","first-page":"7819","DOI":"10.1093\/nar\/gku484","volume":"42","author":"XH Liang","year":"2014","unstructured":"Liang XH, Shen W, Sun H, Prakash TP, Crooke ST (2014) TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cells. Nucleic Acids Res 42:7819\u20137832","journal-title":"Nucleic Acids Res"},{"key":"12_CR67","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1146\/annurev.pharmtox.010909.105654","volume":"50","author":"CF Bennett","year":"2010","unstructured":"Bennett CF, Swayze EE (2010) RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform. Annu Rev Pharmacol Toxicol 50:259\u2013293","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"12_CR68","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1089\/oli.2006.16.26","volume":"16","author":"KA Lennox","year":"2006","unstructured":"Lennox KA, Sabel JL, Johnson MJ, Moreira BG, Fletcher CA, Rose SD, Behlke MA, Laikhter AL, Walder JA, Dagle JM (2006) Characterization of modified antisense oligonucleotides in Xenopus laevis embryos. Oligonucleotides 16:26\u201342","journal-title":"Oligonucleotides"},{"key":"12_CR69","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1093\/nar\/25.22.4429","volume":"25","author":"SM Freier","year":"1997","unstructured":"Freier SM, Altmann KH (1997) The ups and downs of nucleic acid duplex stability: structure-stability studies on chemically-modified DNA:RNA duplexes. Nucleic Acids Res 25:4429\u20134443","journal-title":"Nucleic Acids Res"},{"key":"12_CR70","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1007\/s11095-010-0156-0","volume":"27","author":"KA Lennox","year":"2010","unstructured":"Lennox KA, Behlke MA (2010) A direct comparison of anti-microRNA oligonucleotide potency. Pharm Res 27:1788\u20131799","journal-title":"Pharm Res"},{"key":"12_CR71","doi-asserted-by":"publisher","first-page":"9645","DOI":"10.1021\/acs.jmedchem.6b00551","volume":"59","author":"WB Wan","year":"2016","unstructured":"Wan WB, Seth PP (2016) The medicinal chemistry of therapeutic oligonucleotides. J Med Chem 59:9645\u20139667","journal-title":"J Med Chem"},{"key":"12_CR72","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1093\/nar\/23.11.2019","volume":"23","author":"LL Cummins","year":"1995","unstructured":"Cummins LL, Owens SR, Risen LM, Lesnik EA, Freier SM, McGee D, Guinosso CJ, Cook PD (1995) Characterization of fully 2\u2019-modified oligoribonucleotide hetero- and homoduplex hybridization and nuclease sensitivity. Nucleic Acids Res 23:2019\u20132024","journal-title":"Nucleic Acids Res"},{"key":"12_CR73","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0167-4781(99)00138-4","volume":"1489","author":"M Manoharan","year":"1999","unstructured":"Manoharan M (1999) 2\u2019-carbohydrate modifications in antisense oligonucleotide therapy: importance of conformation, configuration and conjugation. Biochim Biophys Acta 1489:117\u2013130","journal-title":"Biochim Biophys Acta"},{"key":"12_CR74","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1021\/ja9822862","volume":"120","author":"AA Koshkin","year":"1998","unstructured":"Koshkin AA, Nielsen P, Meldgaard M, Rajwanshi VK, Singh SK, Wengel J (1998) LNA (locked nucleic acid): an RNA mimic forming exceedingly stable LNA:LNA duplexes. J Am Chem Soc 120:2","journal-title":"J Am Chem Soc"},{"key":"12_CR75","doi-asserted-by":"publisher","first-page":"6729","DOI":"10.1093\/nar\/gkq505","volume":"38","author":"A Eichert","year":"2010","unstructured":"Eichert A, Behling K, Betzel C, Erdmann VA, Furste JP, Forster C (2010) The crystal structure of an \u2018All Locked\u2019 nucleic acid duplex. Nucleic Acids Res 38:6729\u20136736","journal-title":"Nucleic Acids Res"},{"key":"12_CR76","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.1021\/ja012288d","volume":"124","author":"M Petersen","year":"2002","unstructured":"Petersen M, Bondensgaard K, Wengel J, Jacobsen JP (2002) Locked nucleic acid (LNA) recognition of RNA: NMR solution structures of LNA:RNA hybrids. J Am Chem Soc 124:5974\u20135982","journal-title":"J Am Chem Soc"},{"key":"12_CR77","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1093\/nar\/30.9.1911","volume":"30","author":"J Kurreck","year":"2002","unstructured":"Kurreck J, Wyszko E, Gillen C, Erdmann VA (2002) Design of antisense oligonucleotides stabilized by locked nucleic acids. Nucleic Acids Res 30:1911\u20131918","journal-title":"Nucleic Acids Res"},{"key":"12_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1074-5521(00)00058-2","volume":"8","author":"DA Braasch","year":"2001","unstructured":"Braasch DA, Corey DR (2001) Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA. Chem Biol 8:1\u20137","journal-title":"Chem Biol"},{"key":"12_CR79","doi-asserted-by":"publisher","first-page":"13233","DOI":"10.1021\/bi0485732","volume":"43","author":"B Vester","year":"2004","unstructured":"Vester B, Wengel J (2004) LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA. Biochemistry 43:13233\u201313241","journal-title":"Biochemistry"},{"key":"12_CR80","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/S0960-894X(98)00366-7","volume":"8","author":"R Kumar","year":"1998","unstructured":"Kumar R, Singh SK, Koshkin AA, Rajwanshi VK, Meldgaard M, Wengel J (1998) The first analogues of LNA (locked nucleic acids): phosphorothioate-LNA and 2\u2019-thio-LNA. Bioorg Med Chem Lett 8:2219\u20132222","journal-title":"Bioorg Med Chem Lett"},{"key":"12_CR81","doi-asserted-by":"publisher","first-page":"9973","DOI":"10.1021\/bi025907j","volume":"41","author":"AN Elayadi","year":"2002","unstructured":"Elayadi AN, Braasch DA, Corey DR (2002) Implications of high-affinity hybridization by locked nucleic acid oligomers for inhibition of human telomerase. Biochemistry 41:9973\u20139981","journal-title":"Biochemistry"},{"key":"12_CR82","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1081\/NCN-120022731","volume":"22","author":"M Frieden","year":"2003","unstructured":"Frieden M, Hansen HF, Koch T (2003) Nuclease stability of LNA oligonucleotides and LNA-DNA chimeras. Nucleosides Nucleotides Nucleic Acids 22:1041\u20131043","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"12_CR83","doi-asserted-by":"publisher","first-page":"5633","DOI":"10.1073\/pnas.97.10.5633","volume":"97","author":"C Wahlestedt","year":"2000","unstructured":"Wahlestedt C, Salmi P, Good L, Kela J, Johnsson T, Hokfelt T, Broberger C, Porreca F, Lai J, Ren K et al (2000) Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc Natl Acad Sci U S A 97:5633\u20135638","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12_CR84","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/nar\/gkl1071","volume":"35","author":"EE Swayze","year":"2007","unstructured":"Swayze EE, Siwkowski AM, Wancewicz EV, Migawa MT, Wyrzykiewicz TK, Hung G, Monia BP, Bennett CF (2007) Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals. Nucleic Acids Res 35:687\u2013700","journal-title":"Nucleic Acids Res"},{"key":"12_CR85","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1089\/nat.2013.0436","volume":"23","author":"PH Hagedorn","year":"2013","unstructured":"Hagedorn PH, Yakimov V, Ottosen S, Kammler S, Nielsen NF, Hog AM, Hedtjarn M, Meldgaard M, Moller MR, Orum H et al (2013) Hepatotoxic potential of therapeutic oligonucleotides can be predicted from their sequence and modification pattern. Nucleic Acid Ther 23:302\u2013310","journal-title":"Nucleic Acid Ther"},{"key":"12_CR86","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1093\/nar\/gkv1210","volume":"44","author":"SA Burel","year":"2016","unstructured":"Burel SA, Hart CE, Cauntay P, Hsiao J, Machemer T, Katz M, Watt A, Bui HH, Younis H, Sabripour M et al (2016) Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts. Nucleic Acids Res 44:2093\u20132109","journal-title":"Nucleic Acids Res"},{"key":"12_CR87","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.omtn.2017.11.004","volume":"10","author":"A Dieckmann","year":"2018","unstructured":"Dieckmann A, Hagedorn PH, Burki Y, Brugmann C, Berrera M, Ebeling M, Singer T, Schuler F (2018) A sensitive in vitro approach to assess the hybridization-dependent toxic potential of high affinity gapmer oligonucleotides. Mol Ther Nucleic Acids 10:45\u201354","journal-title":"Mol Ther Nucleic Acids"},{"key":"12_CR88","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.1093\/nar\/gku142","volume":"42","author":"AD Burdick","year":"2014","unstructured":"Burdick AD, Sciabola S, Mantena SR, Hollingshead BD, Stanton R, Warneke JA, Zeng M, Martsen E, Medvedev A, Makarov SS et al (2014) Sequence motifs associated with hepatotoxicity of locked nucleic acid \u2013 modified antisense oligonucleotides. Nucleic Acids Res 42:4882\u20134891","journal-title":"Nucleic Acids Res"},{"key":"12_CR89","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.omtn.2017.07.003","volume":"8","author":"PJ Kamola","year":"2017","unstructured":"Kamola PJ, Maratou K, Wilson PA, Rush K, Mullaney T, McKevitt T, Evans P, Ridings J, Chowdhury P, Roulois A et al (2017) Strategies for in vivo screening and mitigation of hepatotoxicity associated with antisense drugs. Mol Ther Nucleic Acids 8:383\u2013394","journal-title":"Mol Ther Nucleic Acids"},{"key":"12_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/srep30377","volume":"6","author":"T Kasuya","year":"2016","unstructured":"Kasuya T, Hori S, Watanabe A, Nakajima M, Gahara Y, Rokushima M, Yanagimoto T, Kugimiya A (2016) Ribonuclease H1-dependent hepatotoxicity caused by locked nucleic acid-modified gapmer antisense oligonucleotides. Sci Rep 6:30377","journal-title":"Sci Rep"},{"key":"12_CR91","doi-asserted-by":"publisher","first-page":"8638","DOI":"10.1093\/nar\/gkv857","volume":"43","author":"PJ Kamola","year":"2015","unstructured":"Kamola PJ, Kitson JD, Turner G, Maratou K, Eriksson S, Panjwani A, Warnock LC, Douillard Guilloux GA, Moores K, Koppe EL et al (2015) In silico and in vitro evaluation of exonic and intronic off-target effects form a critical element of therapeutic ASO gapmer optimization. Nucleic Acids Res 43:8638\u20138650","journal-title":"Nucleic Acids Res"},{"key":"12_CR92","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1089\/nat.2021.0071","volume":"32","author":"PH Hagedorn","year":"2022","unstructured":"Hagedorn PH, Brown JM, Easton A, Pierdomenico M, Jones K, Olson RE, Mercer SE, Li D, Loy J, Hog AM et al (2022) Acute neurotoxicity of antisense oligonucleotides after intracerebroventricular injection into mouse brain can be predicted from sequence features. Nucleic Acid Ther 32:151\u2013162","journal-title":"Nucleic Acid Ther"},{"key":"12_CR93","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1089\/nat.2015.0576","volume":"26","author":"S Kakiuchi-Kiyota","year":"2016","unstructured":"Kakiuchi-Kiyota S, Whiteley LO, Ryan AM, Mathialagan N (2016) Development of a method for profiling protein interactions with LNA-modified antisense oligonucleotides using protein microarrays. Nucleic Acid Ther 26:93\u2013101","journal-title":"Nucleic Acid Ther"},{"key":"12_CR94","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1038\/mtna.2013.72","volume":"3","author":"L Pedersen","year":"2014","unstructured":"Pedersen L, Hagedorn PH, Lindholm MW, Lindow M (2014) A kinetic model explains why shorter and less affine enzyme-recruiting oligonucleotides can be more potent. Mol Ther Nucleic Acids 3:e149","journal-title":"Mol Ther Nucleic Acids"},{"key":"12_CR95","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-60327-429-6_1","volume":"453","author":"NR Markham","year":"2008","unstructured":"Markham NR, Zuker M (2008) UNAFold: software for nucleic acid folding and hybridization. Methods Mol Biol 453:3\u201331","journal-title":"Methods Mol Biol"},{"key":"12_CR96","doi-asserted-by":"publisher","first-page":"W361","DOI":"10.1093\/nar\/gku406","volume":"42","author":"I Paz","year":"2014","unstructured":"Paz I, Kosti I, Ares Jr.M, Cline M, Mandel-Gutfreund Y (2014) RBPmap: a web server for mapping binding sites of RNA-binding proteins. Nucleic Acids Res 42:W361\u2013W367","journal-title":"Nucleic Acids Res"},{"key":"12_CR97","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1093\/nar\/gkx056","volume":"45","author":"PH Hagedorn","year":"2017","unstructured":"Hagedorn PH, Hansen BR, Koch T, Lindow M (2017) Managing the sequence-specificity of antisense oligonucleotides in drug discovery. Nucleic Acids Res 45:2262\u20132282","journal-title":"Nucleic Acids Res"},{"key":"12_CR98","doi-asserted-by":"publisher","first-page":"5366","DOI":"10.1093\/nar\/gky397","volume":"46","author":"PH Hagedorn","year":"2018","unstructured":"Hagedorn PH, Pontoppidan M, Bisgaard TS, Berrera M, Dieckmann A, Ebeling M, Moller MR, Hudlebusch H, Jensen ML, Hansen HF et al (2018) Identifying and avoiding off-target effects of RNase H-dependent antisense oligonucleotides in mice. Nucleic Acids Res 46:5366\u20135380","journal-title":"Nucleic Acids Res"},{"key":"12_CR99","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/978-1-4939-0733-5_2","volume":"1160","author":"G Johnson","year":"2014","unstructured":"Johnson G, Nour AA, Nolan T, Huggett J, Bustin S (2014) Minimum information necessary for quantitative real-time PCR experiments. Methods Mol Biol 1160:5\u201317","journal-title":"Methods Mol Biol"},{"key":"12_CR100","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL et al (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611\u2013622","journal-title":"Clin Chem"}],"container-title":["Methods in Molecular Biology","Gapmers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5476-7_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:04:06Z","timestamp":1790769846000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5476-7_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071654750","9781071654767"],"references-count":100,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5476-7_12","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 October 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}